Crossmark

Efficacy of chimeric antigen receptor natural killer cells in treatment of ovarian cancer. A meta-analysis of pre-clinical studies

Crossref DOI link: https://doi.org/10.1007/s12026-026-09750-w

Published Online: 2026-02-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmed, Nabeel https://orcid.org/0009-0009-7550-213X
Jabeen, Jawaria https://orcid.org/0009-0009-4300-0442
Rehman, Malja https://orcid.org/0009-0001-0524-1941
Noor, Safa https://orcid.org/0009-0002-7530-7253
Tahseen, Sana https://orcid.org/0009-0002-6652-2912
Qamar, Asmaa https://orcid.org/0009-0009-5199-6876
Anas, Muhammad https://orcid.org/0009-0006-7020-8589
Khalid, Muhammad Muneeb https://orcid.org/0009-0000-5111-3900
Ahmad, Taseer https://orcid.org/0000-0003-4545-9598
Wang, Weiqun

Lyu, Lechun https://orcid.org/0000-0003-0095-4050
License Information

Text and Data Mining valid from 2026-02-20

Version of Record valid from 2026-02-20
More Information

Article History

Received: 29 October 2025

Accepted: 26 January 2026

First Online: 20 February 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.

: Not applicable.